Skip to main content

Table 5 Factors associated with less than expected improvement in the CD4 + cell count over time by advanced HIV disease status

From: Burden, clinical presentation and risk factors of advanced HIV disease in pregnant Mozambican women

Variable

Unadjusted

Adjusted

OR

95%CI

P-value

OR

95% CI

P-value

Age group (years)

 < 20

1

 

0.012

1

 

0.018

20–24

2.24

1.16; 4.34

2.27

1.17; 4.40

25–34

1.31

0.7; 2.48

1.34

0.71; 2.55

 > 35

1.59

0.77; 3.30

1.56

0.74; 3.28

Gestational age at first ANC visit

1.00

0.97; 1.03

0.957

1.17

0.8; 1.71

0.954

WHO Clinical Stage

I

1

 

 < 0.001

1

 

0.002

II

0.66

0.31; 1.40

0.73

0.34; 1.56

III

0.80

0.36; 1.79

0.87

0.39; 1.98

IV

8.33

2.61; 26.56

9.59

2.94; 31.27

CD4 count (cells/mm3)

 < 200

1

 

0.056

1

 

0.045

 ≥ 200

1.73

0.89; 3.83

1.92

0.97; 3.83

ART start

Before first ANC visit

1

 

0.606

1

 

0.417

After first ANC visit

1.13

0.78; 1.62

1.34

0.79; 2.27

  1. P value (LR-test). Number of observations: 1298 (unadjusted and adjusted ORs were based only on observations with complete information on all variables). ART Antiretroviral therapy, ANC Antenatal care, WHO Word health organization